drugset / Trial / NCT05140525

Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH

NCT05140525

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The main goal of this study is to determine the effects of combination medical therapy (Riociguat and Macitentan) and balloon pulmonary angioplasty (BPA) on hemodynamics and right ventricular (RV) function (including advanced assessments of RV-pulmonary artery (PA) coupling from invasive hemodynamics) in participants with inoperable or post-PTE residual CTEPH.

Timeline

Start
2025-01-27
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Macitentan Other / unclassified 10 mg Oral
Comparator Riociguat Other / unclassified 1 mg Oral
Comparator Riociguat Other / unclassified 2.5 mg Oral